Fractal Analyt. (FRACTAL)
Fast GrowerFairStock Score: 24/100 — RISKY
Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹834.35 |
| Market Cap | ₹14,347.91 Cr |
| P/E Ratio | 43.66 |
| ROCE | 12.05% |
| ROE | —% |
| Dividend Yield | 0% |
| Profit Growth | 77.1% |
| Debt/Equity | 0.13 |
| Sales Growth | 20% |
| Free Cash Flow | ₹206 Cr |
| Promoter Holding | 16.97% |
| 52-Week Range | ₹733.7 — ₹1,119.6 |
| Sector | IT - Software |
| Book Value | ₹191.15 |
Strengths
- Five-year revenue CAGR of 25.93% shows strong top-line growth
- Latest quarter sales of ₹1,559 Cr and annual sales growth of 19.86% indicate continued demand
- Low debt-to-equity of 0.21 provides financial cushion
- Positive free cash flow of ₹206 Cr supports operations and potential reinvestment
- ROCE of 12.05% shows reasonable capital efficiency
Concerns
- Profit growth is negative at -2.35%, while sales are growing, indicating margin pressure
- P/E of 76.14 and PEG of 3.83 imply an extremely expensive valuation with little safety margin
- Promoter holding of only 16.97% raises corporate governance and alignment concerns
- Piotroski F-Score of 4/9 suggests weak overall financial health
AI Analysis
When I evaluate Fractal Analyt, I first remind myself that price is what you pay, value is what you get. At ₹962, the market is asking me to pay 76 times earnings and 7.3 times book value for a business whose latest profit actually fell 2.35%. That is a steep price for any company, let alone one in the intensely competitive software consulting space. The revenue story is real: sales grew 19.86% last year, and five-year revenue CAGR is an impressive 25.93%. The latest quarter shows ₹1,559 Cr in sales and ₹71 Cr in net profit. But the disconnect between top-line growth and bottom-line decline worries me. A quality business must eventually convert revenue into shareholder earnings; so far, the profit engine is sputtering. The balance sheet is reasonably clean, with debt-to-equity of only 0.21 and free cash flow of ₹206 Cr. ROCE of 12.05% is respectable but not exceptional, especially for a stock trading at this valuation. Promoter holding of just 16.97% is a red flag in India; I want owners heavily aligned with minority shareholders. The Piotroski F-Score of 4/9 also signals weak financial health. This is a fast grower, but a fast grower at a PEG of 3.83 is dangerous. Graham would say the margin of safety is absent. I cannot pay today's price for a business whose profits are not yet matching its growth. It may become a wonderful investment if earnings catch up, but I would wait for a better price or clear proof of margin expansion.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer